Welcome to BiOasis Corporation

Diagnosis of Alzheimer's Blood Brain Barrier Delivery Platform

The Science of P97 Science Board Members Intellectual Property Validating Studies Publications

Corporate Profile The Market Team Literature and Inquiries News Releases Investors

Robin (Rob) B. Hutchison, Chairman & CEO
Mr. Hutchison, the founder of biOasis Technologies Inc., is also the founder of several companies including eCharge Corporation (“eCharge”) of Seattle, Washington, which specializes in alternative payment methods for the Internet. He served as the President and Chief Technical Officer of eCharge and played an integral role in raising over US$90 million in private funding. Mr. Hutchison pioneered and holds the patents on unique digital certificate technology, which enabled eCharge to provide secure Internet commerce transactions. Mr. Hutchison retired from eCharge in 2002 but still remains as the key Scientific Advisor to the company.		Prior to co-founding eCharge, Mr. Hutchison was the President of Canada-based SNI Corporation, which specializes in the integration of SUN Microsystems UNIX-based systems with the Internet and computer firewall security. He also served as the Western regional director of sales and operations for Everex Canada Inc. Since then, he has assisted in the development of several start-ups and mature technology companies. Mr. Hutchison is a member of the Board of Directors of Golden Goliath Resources.
Dr. Terry Pearson, Board Member
Dr. Pearson, Ph.D. is Senior Scientific Advisor to the Plasma Proteome Institute, Washington, DC www.plasmaproteome.org The Institute aims to foster a comprehensive exploration of the proteins of human blood plasma (the plasma proteome) and the rapid application of novel protein measurements in clinical diagnostics. Dr. Pearson is a professor in the Department of Biochemistry and Microbiology at the University of Victoria where he is involved in research on tropical diseases and the use of monoclonal antibodies and mass spectrometry for protein detection in a variety of applications. Dr. Pearson received his B.Sc. and Ph.D. degrees in microbiology and immunology from the University of British Columbia in Vancouver. After postdoctoral work in tumor immunology at the Medical Research Council Laboratory in Cambridge, England, in the laboratory of Dr. Sydney Brenner, Dr. Pearson worked as a staff scientist in its Division of Cell Biology. While in Cambridge he was involved in the early stages of the development of monoclonal antibody technology with Georges Kohler and Cesar Milstein.		He was a staff scientist at the International Laboratory for Research on Animal Diseases in Nairobi, Kenya where he introduced monoclonal antibodies to Africa. Since then his research has focused on the biochemical and immunological analysis of tropical protozoan parasites, mainly trypanosomes, the causative agents of African sleeping sickness. Currently his research team uses protein micro chemical techniques and mass spectrometry as tools for identification of molecular interactions between infectious agents and insect vectors. His research also focuses on development of quantitative mass spectrometric methods for application to clinical diagnostics, an approach that involves development of antibody probes for proteins in deep proteomes such as human plasma. He served as a Trustee of the Terry Fox Medical Research Foundation and as a Director of the Science Council of British Columbia. Dr. Pearson has published more than 150 scientific articles, many involving monoclonal antibodies and their use in protein identification and characterization.
Mr George Saunders
George Sanders is a mining entrepreneur with over 28 years in mining and exploration finance experience. He has worked in the entrepreneurial end of the mining retail business. George is currently the President and a Director of Goldcliff Resource Corporation. He is a Director of Bitterroot Resources Ltd. and Silvercrest Mines Inc. He was President and Director of Wescan Goldfields Inc.		and also Vice President, Corporate Development of Shore Gold Inc. He spent over 15 years as a registered representative and precious metals specialist with the investment firm Canaccord Capital Corporation and its predecessor companies. Mr. Sanders has held Corporate Development positions with Richmont Mines Ltd. and Consolidated Cinola Mines
David Clark, Chief Financial Officer & Director
Mr. Clark is a chartered accountant with more than 30 years experience in banking and a wide range of industries, including biotechnology, transaction automation and electronic payments, software, brewing, junior oil and gas, mineral exploration, real estate development, and environmental technologies. He has acted in senior roles in these companies, principally as a		director, President, Chief Financial Officer, or as senior financial or corporate finance consultant. Mr. Clark has managed taking companies public; mergers and acquisitions; and raising significant funds through public and private equity and/or debt. Clark’s banking experience comprises eight years with Security Pacific Bank Canada (now Bank of America Canada), most latterly in the position of Senior Vice-President and CFO.
J. Michael Hutchison, Q.C.
Mr. Hutchison is a lawyer in private practice with offices in Victoria and Vancouver, B.C., for 39 years. He practises primarily in the areas of corporate commercial law, administrative law and civil litigation. He was appointed Queens’ Counsel in 1985. Mr. Hutchison has been and is a member of the Board of Directors in various private corporations, primarily start-up technology related		companies. He was elected a School Trustee for four years, and was a member of and Chairman of the Board of Governors of Camosun College in Victoria, B.C. He has served as the external counsel for the University of Victoria and was general counsel to the Board of Examiners in Optometry of British Columbia for more than thirty years. Currently, he is counsel to and a member of the Board of Directors of the Victoria Heart Institute Foundation.
Craig D. Thomas
Mr. Thomas, is a barrister and solicitor and principal of the law firm of Thomas, Rondeau LLP specializing in the practice of corporate and securities law matters, including structuring and implementation of corporate financing transactions, public and private securities offerings, mergers and acquisitions, registration, reporting and		compliance matters. Mr. Thomas earned his undergraduate degree in 1975 from Harvard College and his Bachelor of Laws degree in 1978 from the University of Alberta. Mr. Thomas has practised law in British Columbia since 1979. Mr. Thomas has served as an officer and director of numerous publicly listed companies.